Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

FDA accepts Avastin BLA for priority review

Dec. 3, 2003

In vitro efficacy of 2-methoxyestradiol in prostate and pancreatic cancer

Dec. 3, 2003

Antiproliferative and cytotoxic effects of aplidine assessed in human cancer cell lines

Dec. 3, 2003

Preclinical and clinical antitumor efficacy and clinical safety of Bay-43-9006

Dec. 3, 2003

Radiosensitizing effects of GW-572016 and use in combination chemotherapy

Dec. 3, 2003

Antitumor effects of irofulven in advanced cancer

Dec. 3, 2003

Antitumor effects of TZT-1027 in advanced cancer patients

Dec. 2, 2003

Efficacy and tolerance of MS-275 in patients with refractory tumors

Dec. 2, 2003

Progression-free survival prolonged in Avastin study in colorectal cancer

Dec. 1, 2003

Enrollment completed in STELLAR 3 pivotal trial of Xyotax

Dec. 1, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 26, 2026.
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026